Addex Therapeutics Ltd Cash And Cash Equivalents
Addex Therapeutics Ltd (ADXN) had Cash And Cash Equivalents of CHF 2.30 million as of 2025-06-30, per its 6-K filed 2025-09-30.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-09-30
- 2025-06-30: Cash And Cash Equivalents 2.30M CHF.
- 2024-12-31: Cash And Cash Equivalents 3.34M CHF.
- 2024-06-30: Cash And Cash Equivalents 3.79M CHF.
- 2023-12-31: Cash And Cash Equivalents 3.87M CHF.
| Period end | Cash And Cash Equivalents | Cash And Cash Equivalents as first filed |
|---|---|---|
| 2025-06-30 | 2.30M CHF 6-K · filed 2025-09-30 | |
| 2024-12-31 | 3.34M CHF 6-K · filed 2025-09-30 | |
| 2024-06-30 | 3.79M CHF 6-K · filed 2025-09-30 | |
| 2023-12-31 | 3.87M CHF 6-K · filed 2025-09-30 | |
| 2023-06-30 | 7.17M CHF 6-K/A · filed 2023-12-21 | |
| 2022-12-31 | 6.96M CHF 20-F · filed 2025-05-15 | |
| 2022-06-30 | 8.81M CHF 6-K/A · filed 2023-12-21 | |
| 2021-12-31 | 20.48M CHF 20-F · filed 2025-05-15 | |
| 2021-06-30 | 18.11M CHF 6-K/A · filed 2022-09-14 | |
| 2020-12-31 | 18.70M CHF 20-F · filed 2024-04-18 | |
| 2019-12-31 | 31.54M CHF 20-F · filed 2022-03-10 | |
| 2018-12-31 | 31.54M CHF 20-F · filed 2023-03-30 | 41.67M CHF 20-F · filed 2020-04-27 |
| 2017-12-31 | 2.58M CHF 20-F · filed 2021-03-11 | |
| 2016-12-31 | 1.41M CHF 20-F · filed 2020-04-27 |